149 related articles for article (PubMed ID: 18630911)
1. NMR structure of the complex between the Tfb1 subunit of TFIIH and the activation domain of VP16: structural similarities between VP16 and p53.
Langlois C; Mas C; Di Lello P; Jenkins LM; Legault P; Omichinski JG
J Am Chem Soc; 2008 Aug; 130(32):10596-604. PubMed ID: 18630911
[TBL] [Abstract][Full Text] [Related]
2. NMR structure of the amino-terminal domain from the Tfb1 subunit of TFIIH and characterization of its phosphoinositide and VP16 binding sites.
Di Lello P; Nguyen BD; Jones TN; Potempa K; Kobor MS; Legault P; Omichinski JG
Biochemistry; 2005 May; 44(21):7678-86. PubMed ID: 15909982
[TBL] [Abstract][Full Text] [Related]
3. Structure of the Tfb1/p53 complex: Insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53.
Di Lello P; Jenkins LMM; Jones TN; Nguyen BD; Hara T; Yamaguchi H; Dikeakos JD; Appella E; Legault P; Omichinski JG
Mol Cell; 2006 Jun; 22(6):731-740. PubMed ID: 16793543
[TBL] [Abstract][Full Text] [Related]
4. Structural and functional characterization of a complex between the acidic transactivation domain of EBNA2 and the Tfb1/p62 subunit of TFIIH.
Chabot PR; Raiola L; Lussier-Price M; Morse T; Arseneault G; Archambault J; Omichinski JG
PLoS Pathog; 2014 Mar; 10(3):e1004042. PubMed ID: 24675874
[TBL] [Abstract][Full Text] [Related]
5. p53 and TFIIEalpha share a common binding site on the Tfb1/p62 subunit of TFIIH.
Di Lello P; Miller Jenkins LM; Mas C; Langlois C; Malitskaya E; Fradet-Turcotte A; Archambault J; Legault P; Omichinski JG
Proc Natl Acad Sci U S A; 2008 Jan; 105(1):106-11. PubMed ID: 18160537
[TBL] [Abstract][Full Text] [Related]
6. Structural properties of the promiscuous VP16 activation domain.
Jonker HR; Wechselberger RW; Boelens R; Folkers GE; Kaptein R
Biochemistry; 2005 Jan; 44(3):827-39. PubMed ID: 15654739
[TBL] [Abstract][Full Text] [Related]
7. A conserved amphipathic helix in the N-terminal regulatory region of the papillomavirus E1 helicase is required for efficient viral DNA replication.
Morin G; Fradet-Turcotte A; Di Lello P; Bergeron-Labrecque F; Omichinski JG; Archambault J
J Virol; 2011 Jun; 85(11):5287-300. PubMed ID: 21450828
[TBL] [Abstract][Full Text] [Related]
8. Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53.
Xiao H; Pearson A; Coulombe B; Truant R; Zhang S; Regier JL; Triezenberg SJ; Reinberg D; Flores O; Ingles CJ
Mol Cell Biol; 1994 Oct; 14(10):7013-24. PubMed ID: 7935417
[TBL] [Abstract][Full Text] [Related]
9. The intrinsically unstructured domain of PC4 modulates the activity of the structured core through inter- and intramolecular interactions.
Jonker HR; Wechselberger RW; Boelens R; Kaptein R; Folkers GE
Biochemistry; 2006 Apr; 45(15):5067-81. PubMed ID: 16605275
[TBL] [Abstract][Full Text] [Related]
10. NMR structure of the human Mediator MED25 ACID domain.
Bontems F; Verger A; Dewitte F; Lens Z; Baert JL; Ferreira E; de Launoit Y; Sizun C; Guittet E; Villeret V; Monté D
J Struct Biol; 2011 Apr; 174(1):245-51. PubMed ID: 20974256
[TBL] [Abstract][Full Text] [Related]
11. Structural Basis for the Interaction between p53 Transactivation Domain and the Mediator Subunit MED25.
Lee MS; Lim K; Lee MK; Chi SW
Molecules; 2018 Oct; 23(10):. PubMed ID: 30360415
[TBL] [Abstract][Full Text] [Related]
12. Human general transcription factor TFIIB: conformational variability and interaction with VP16 activation domain.
Hayashi F; Ishima R; Liu D; Tong KI; Kim S; Reinberg D; Bagby S; Ikura M
Biochemistry; 1998 Jun; 37(22):7941-51. PubMed ID: 9609687
[TBL] [Abstract][Full Text] [Related]
13. Domain architecture of the p62 subunit from the human transcription/repair factor TFIIH deduced by limited proteolysis and mass spectrometry analysis.
Jawhari A; Boussert S; Lamour V; Atkinson RA; Kieffer B; Poch O; Potier N; van Dorsselaer A; Moras D; Poterszman A
Biochemistry; 2004 Nov; 43(45):14420-30. PubMed ID: 15533047
[TBL] [Abstract][Full Text] [Related]
14. High level expression and structural characterisation of herpes simplex virus type I transcriptional activator VP16 (alpha-trans inducing factor).
Spatz AM; Ali SA; Auer M; Graf C; Eibl MM; Steinkasserer A
Biochem Biophys Res Commun; 1998 Oct; 251(1):235-8. PubMed ID: 9790937
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of in vitro interactions implicates TATA-binding protein as a target of the VP16C transcriptional activation region.
Nedialkov YA; Triezenberg SJ
Arch Biochem Biophys; 2004 May; 425(1):77-86. PubMed ID: 15081896
[TBL] [Abstract][Full Text] [Related]
16. Extended string binding mode of the phosphorylated transactivation domain of tumor suppressor p53.
Okuda M; Nishimura Y
J Am Chem Soc; 2014 Oct; 136(40):14143-52. PubMed ID: 25216154
[TBL] [Abstract][Full Text] [Related]
17. Structure of the VP16 transactivator target in the Mediator.
Milbradt AG; Kulkarni M; Yi T; Takeuchi K; Sun ZY; Luna RE; Selenko P; Näär AM; Wagner G
Nat Struct Mol Biol; 2011 Apr; 18(4):410-5. PubMed ID: 21378963
[TBL] [Abstract][Full Text] [Related]
18. Dual-site interactions of p53 protein transactivation domain with anti-apoptotic Bcl-2 family proteins reveal a highly convergent mechanism of divergent p53 pathways.
Ha JH; Shin JS; Yoon MK; Lee MS; He F; Bae KH; Yoon HS; Lee CK; Park SG; Muto Y; Chi SW
J Biol Chem; 2013 Mar; 288(10):7387-98. PubMed ID: 23316052
[TBL] [Abstract][Full Text] [Related]
19. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional characterization of interactions involving the Tfb1 subunit of TFIIH and the NER factor Rad2.
Lafrance-Vanasse J; Arseneault G; Cappadocia L; Chen HT; Legault P; Omichinski JG
Nucleic Acids Res; 2012 Jul; 40(12):5739-50. PubMed ID: 22373916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
